Independent pharmacies can pay wholesalers, employees, rent and technology costs before every submitted claim becomes collected cash. Prescription inventory may turn quickly while reimbursement, reversals, reconciliations and payer or PBM terms create a different cash-flow schedule. This guide explains how to define the need, measure the actual collection cycle, protect inventory controls and compare potential funding paths without treating billed sales or projected reimbursements as guaranteed revenue.
Define the exact pharmacy funding need
Separate recurring operating needs from longer-term investments. A temporary reimbursement gap, seasonal vaccine or prescription inventory build, dispensing-system replacement and complete pharmacy acquisition each require a different budget and repayment plan.
List prescription inventory, front-end inventory, payroll, benefits, rent, insurance, delivery, security, licensing, technology, professional fees and contingency separately. Include the dates cash is expected to leave the pharmacy and the conservative dates related revenue may be collected.
The CashMigo pharmacy business funding page provides a focused starting point for inventory, working capital, equipment, technology and acquisition needs. Start with the amount required for a defined purpose rather than the maximum amount that might be available.
Measure reimbursements and collected margin
Reconcile prescriptions filled with claims submitted, accepted, rejected, reversed, adjusted and actually paid. Separate cash and front-end sales from third-party reimbursements so the funding request is based on collected business cash rather than gross prescription activity alone.
Review reimbursement timing and gross margin by major payer or PBM relationship at an appropriate aggregated level. Track ingredient acquisition cost, dispensing revenue, fees, reversals, clawbacks or reconciliations under the pharmacy's contracts, while recognizing that contract terminology and treatment can vary.
CMS has publicly recognized that Medicare Part D payment arrangements may affect pharmacy cash flow. Review current CMS pharmacy payment information, applicable contracts and qualified professional guidance rather than relying on an old rule summary. Build a slower-reimbursement case into the cash-flow forecast.
Tell CashMigo what the business needs, how much and how soon. We will review the request and help identify potential next steps.
Check My Funding Options →Plan prescription and front-end inventory
Use pharmacy-system and wholesaler reports to examine inventory by category, acquisition cost, turnover, expiration exposure, return eligibility and reimbursement history. High sales volume does not necessarily produce strong cash flow if inventory cost and reimbursement do not leave enough collected margin.
Document wholesaler terms, credit limits, payment dates, rebates or purchasing commitments and any security interests. Confirm whether the requested financing can be used for the intended inventory and whether another creditor already has a lien or control over business assets.
For a defined inventory build, show product need, historical demand, supplier quote or order, expected dispensing or sale period, storage controls and a plan for unused or expiring items. Avoid using short-duration funding for slow-moving stock without a conservative exit plan.
Budget technology, equipment and security
A project may include dispensing and counting equipment, refrigeration, point-of-sale systems, pharmacy-management software, delivery technology, backup power, security, cameras, counters, shelving or facility improvements. Create a complete budget including installation, data migration, training, maintenance, insurance and downtime.
Equipment financing may fit certain qualifying assets, while a term structure may be considered for a broader renovation or technology project. Compare the useful life of the asset with the payment period and confirm end-of-term ownership, service and replacement responsibilities.
Protect patient and prescription information throughout the process. Do not upload protected health information, patient identifiers, prescription files, pharmacy-system credentials or unredacted claim records through a general website form. Use aggregated business reports initially and an approved secure channel only when specifically required.
Evaluate a pharmacy acquisition carefully
Build a complete sources-and-uses schedule covering purchase price, eligible inventory, equipment, lease or real estate, professional fees, licensing, technology conversion, staff transition and post-closing working capital. Identify what is included in the price and how inventory will be counted and adjusted at closing.
Review historical tax returns and financial statements, bank activity, claim and collection summaries, payer and PBM concentration, wholesaler agreements, licenses, audits, chargebacks or recoupments, prescription and front-end mix, controlled-substance procedures, staffing, leases, equipment and current obligations with qualified advisers.
The Federal Trade Commission has published staff research on PBM practices affecting pharmacy markets. A buyer should examine the target's actual contracts and reimbursements rather than assuming industry averages will continue after ownership changes. Confirm which licenses, contracts and network relationships transfer or require new approval.
Compare potential funding paths and prepare records
A business line of credit may fit a qualifying established pharmacy with recurring short-term inventory or reimbursement gaps and a reliable way to reduce each draw. Review draw costs, payments, renewal conditions and whether availability can change.
Working capital or a business term loan may support a defined technology, renovation or expansion plan. SBA financing may be considered for a qualifying acquisition or other eligible use. Product availability, permitted uses, contribution, collateral and documentation depend on the applicant, provider and final transaction.
Useful starting records may include business bank statements, financial statements, aggregated prescription and front-end sales, reimbursement and reversal summaries, payer or PBM concentration, inventory and wholesaler reports, payroll, current debt and a clear use-of-funds budget. Share only non-sensitive information through CashMigo's 60 second funding check or call 1-844-617-CASH.
Frequently asked questions
What pharmacy expenses may business funding support?
Depending on the product and final agreement, potential uses may include eligible prescription or front-end inventory, payroll, technology, equipment, security, renovation, working capital, acquisition or expansion.
Can a pharmacy use funding for prescription inventory?
Potentially. Providers may review supplier terms, inventory records, turnover, expiration and return practices, reimbursement timing, margins, cash flow, liens and current obligations.
Do billed prescriptions count the same as collected revenue?
No. Claims can be rejected, reversed, adjusted or paid on different schedules. A funding review may focus on cash actually collected and the pharmacy's documented reimbursement pattern.
Can funding help buy an existing pharmacy?
Potentially. Providers may review the purchase terms, valuation, licenses, historical financials, reimbursements, payer and PBM concentration, wholesalers, inventory, buyer experience, contribution and transition plan.
What information should not be entered in the funding check?
Do not enter patient names, dates of birth, prescription information, insurance identifiers, Social Security numbers, pharmacy-system credentials or other protected health information. Begin with non-sensitive business information.
How should a pharmacy compare funding offers?
Compare net proceeds, payment amount and frequency, complete cost, term, collateral, guarantees, fees, permitted uses, renewal conditions and early-payoff treatment against conservative collected cash flow.
